Elisabeth Manville
Feb 29, 2012

Ultrasound technology effective in detecting cirrhosis resulting from recurrent hepatitis C

Mayo Clinic researchers have confirmed the excellent accuracy of ultrasound-based transient elastography (TE) in diagnosing cirrhosis of the liver due to the recurrence of hepatitis C virus (HCV) infection in patients who have had a liver transplant. Patients who are HCV RNA-positive at the time of their transplant are at risk for HCV reinfection in which excess fibrotic tissue can develop more quickly, resulting in rapid progression of cirrhosis. The research team looked at studies of the diagnostic accuracy of ultrasound-based TE, which measures liver stiffness to assess fibrosis. “The current gold standard for determining liver disease severity and progression is liver biopsy,” explains lead author Dr. Jayant Talwalkar. “However, biopsy following liver transplantation may not accurately determine fibrosis severity and non-invasive imaging technology has advanced to more accurately assess the severity of liver injury which includes an indirect assessment of elevated portal pressure.”

Companies
1
Patents
1
0 Comments
Related Articles
Stem cells could help create better understanding of hepatitis C, develop treatments
Researchers from Massachusetts Institute of Technology, Rockefeller University and the Medical College of Wisconsin have developed liver-like cells from induced... Read More
UCLA researchers identify peptide that inhibits replication of hepatitis C virus
Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a cell-permeable peptide that inhibits a hepatitis C virus protein and... Read More
Kristin Wall
Feb 27, 2012
Hepatitis C research: Fighting the 'Silent Epidemic'
A study released last week reported that Hepatitis C, the 'silent epidemic,' now kills more people in the US every... Read More